Taysha Gene Therapies
TSHA
HK$20.96
Share price
0.75%
Change (1 day)
17.17%
Change (1 year)
Taysha Gene Therapies (TSHA) - Total debt
Total debt on the balance sheet as of March 2025 : HK$0.48 Billion
According to Taysha Gene Therapies's latest financial reports the company's total debt is HK$0.48 Billion. A company’s total debt is the sum of all current and non-current debts.
Taysha Gene Therapies - Total debt on balance sheet (from 2020 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | HK$0.49 B | 2.78% |
| 2023-12-31 | HK$0.47 B | 1.93% |
| 2022-12-31 | HK$0.46 B | -4.82% |
| 2021-12-31 | HK$0.49 B | |
| 2020-12-31 | N/A |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | HK$25.21 M | -94.76% | 🇺🇸 USA |